Trademark: 78262176
Status Date
Friday, October 11, 2013
Registration Number
3214651
Registration Date
Tuesday, March 6, 2007
Filing Date
Friday, June 13, 2003
Published for Opposition
Tuesday, September 5, 2006
Cancellation Date
Friday, October 11, 2013
1 Chemical and biochemical products for use in gene delivery technology, namely, enzymes, proteins, growth factors and chemicals for in-vitro use in laboratories and for analysis in gene delivery technology; micro-organisms, cell cultures, plasmids and cultures of micro-organisms, deoxyribonucleic acid sequences, cloning vehicles and recombinant deoxyribonucleic acid variations thereof, all for in-vivo use in gene delivery technology
5 Gene therapy and prophylaxis products, namely gene transfer, regulation, modulation and delivery products for the treatment of motor neurone disease, blood disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, vascular disorders, disorders arising from improper vascularization and single gene disorders; pharmaceutical substances and preparations namely, vaccines, genetically engineered proteins enzymes and enzyme preparations for medical diagnostic use; retroviral vector and retroviral vector manufacturing preparations for use in gene delivery; pharmaceutical and biochemical preparations for the treatment of single gene disorders
10 Instruments and apparatus for the administration of gene and antibody-based therapy and prophylaxis preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes, all for the treatment of single gene disorders, cancer, diseases of the nervous system, inflammatory and auto-immune diseases, blood disorders, vascular disorders and disorders arising from inappropriate vascularization
42 Scientific and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new technology for others in the field of biotechnology; licensing of intellectual property; product development consultation relating to gene therapy products; consultation services in the fields of medical and scientific research in the field of professional gene therapy
Oct 11, 2013
Cancelled Sec. 8 (6-Yr)
Mar 6, 2007
Registered-Principal Register
Jan 23, 2007
1(B) Basis Deleted; Proceed To Registration
Jan 23, 2007
Notice Of Allowance Cancelled
Dec 26, 2006
Paper Received
Nov 28, 2006
Noa Mailed - Sou Required From Applicant
Sep 5, 2006
Published For Opposition
Aug 16, 2006
Notice Of Publication
Jul 11, 2006
Law Office Publication Review Completed
Jul 7, 2006
Assigned To Lie
Jul 3, 2006
Examiners Amendment Mailed
Jul 3, 2006
Approved For Pub - Principal Register
Jul 3, 2006
Examiner's Amendment Entered
Jul 3, 2006
Examiners Amendment -Written
Jun 7, 2006
Teas/Email Correspondence Entered
May 31, 2006
Correspondence Received In Law Office
May 31, 2006
Teas Response To Office Action Received
Dec 6, 2005
Non-Final Action Mailed
Dec 6, 2005
Non-Final Action Written
Nov 10, 2005
Data Modification Completed
Oct 17, 2005
Amendment From Applicant Entered
Oct 3, 2005
Correspondence Received In Law Office
Oct 3, 2005
Paper Received
Mar 31, 2005
Letter Of Suspension Mailed
Mar 30, 2005
Suspension Letter Written
Mar 24, 2005
Teas Change Of Correspondence Received
Mar 9, 2005
Examiner's Amendment Entered
Mar 8, 2005
Examiners Amendment E-Mailed
Mar 8, 2005
Examiners Amendment -Written
Feb 14, 2005
Amendment From Applicant Entered
Jan 28, 2005
Correspondence Received In Law Office
Jan 28, 2005
Teas Response To Office Action Received
Aug 4, 2004
Non-Final Action Mailed
Jun 21, 2004
Amendment From Applicant Entered
Jun 21, 2004
Correspondence Received In Law Office
Jun 21, 2004
Teas Response To Office Action Received
Dec 22, 2003
Non-Final Action E-Mailed
Dec 20, 2003
Assigned To Examiner
Trademark Alertz updated from USPTO on 2030-01-24
